Relationship of Serum Iron and Lipemic Levels with Inflammatory Biomarkers and Oxidative Stress in Diabetic Nephropathy

Authors

  • Hanan M. Al-Nadawi Department of Chemistry, College of Science, University of Diyala, Baquba City,
  • Waseem Yousif M Al-Dulaimy Department of Chemistry, C ollege of Science, University of Diyal https://orcid.org/0009-0009-0897-0697

DOI:

https://doi.org/10.24237/ASJ.03.02.862B

Abstract

Type 2 diabetes is a systemic inflammatory condition with hyperglycemia, insulin resistance, and insulin secretion defects. It increases cardiovascular risk and leads to oxidative stress and inflammation. Diabetic nephropathy, a major microvascular complication, is caused by high iron intake or storage, causing hyperglycemia, insulin resistance, and pancreatic dysfunction. Targeting oxidative stress is crucial for managing DN. Researchers at Baquba General Hospital's Ibn Sina Dialysis Center studied iron levels in patients with diabetic nephropathy from October 2023 to January 2024. Eighty adults with no prior conditions, malnutrition, or inflammatory illnesses were screened. The study included 40 participants as a control group and involved blood tests for serum lipids, iron, , C-reactive protein, IL-6, glutathione peroxidase, and superoxide dismutase. The study also determined BMI, a person's body mass index, by dividing their mass by their height. Biomarker estimation was performed once in all subjects. Statistical analysis assessed data homogeneity, normal distribution, and normality using an independent samples t-test. The study analyzed clinical demographics, including age and BMI, and found significant differences in albumin levels and lipid variables between patients and healthy individuals. The average age of patients was 59.3375±10.0, while the control group had a lower BMI. The study also found significant changes in cholesterol, triglycerides, LDL, and HDL levels between patients and control groups. No significant correlation was found between iron and oxidative stress, lipid profile, or glutathione peroxidase.

Downloads

Download data is not yet available.

References

[1] JM. Fernández-Real, D. McClain, M. Manco, Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes, Diabetes care,38(11), 2169-76(2015), DOI(https://doi.org/10.2337/dc14-3082)

[2] Y. Feng, Q. Feng, Y. Lv, X. Song, H. Qu, Y. Chen, The relationship between iron metabolism, stress hormones, and insulin resistance in gestational diabetes mellitus, Nutrition & diabetes, 10(1), 17(2020), DOI(https://doi.org/10.1038/s41387-020-0122-9)

[3] P. Krisai, S. Leib, S. Aeschbacher, T. Kofler, M. Assadian, A. Maseli, Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults, European journal of internal medicine, 32, 31-37(2016), DOI(https://doi.org/10.1016/j.ejim.2016.03.017)

[4] JS. Choi, I-U. Koh, HJ. Lee, WH. Kim, J. Song, Effects of excess dietary iron and fat on glucose and lipid metabolism, The Journal of nutritional biochemistry, 24(9), 1634-44(2013), DOI(https://doi.org/10.1016/j.jnutbio.2013.02.004)

[5] MK. Sagoo, L. Gnudi, Diabetic nephropathy: an overview, Diabetic Nephropathy: Methods and Protocols, 3-7(2020), DOI(https://doi.org/10.1007/978-1-4939-9841-8_1)

[6] N. Vodošek Hojs, S. Bevc, R. Ekart, R. Hojs, Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy, Antioxidants, 9(10), 925(2020), DOI(https://doi.org/10.3390/antiox9100925)

[7] A. Yiannikourides, GO. Latunde-Dada, A short review of iron metabolism and pathophysiology of iron disorders, Medicines, 6(3), 85(2019), DOI(https://doi.org/10.3390/medicines6030085)

[8] F. Oliveira, S. Rocha, R. Fernandes, Iron metabolism: from health to disease, Journal of clinical laboratory analysis, 28(3), 210-218(2014), DOI(https://doi.org/10.1002/jcla.21668)

[9] JH. Dominguez, Y. Liu, KJ. Kelly, Renal iron overload in rats with diabetic nephropathy, Physiological Reports, 3(12), e12654(2015), DOI(https://doi.org/10.14814/phy2.12654)

[10] K. Chaudhary, A. Chilakala, S. Ananth, A. Mandala, R. Veeranan-Karmegam, FL. Powell, Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload, American Journal of Physiology-Renal Physiology, 317(2), F512-F7(2019), DOI(https://doi.org/10.1152/ajprenal.00184.2019)

[11] V. Rao, LV. Rao, SH. Tan, M. Candasamy, SK. Bhattamisra, Diabetic nephropathy: an update on pathogenesis and drug development, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(1), 754-762(2019), DOI(https://doi.org/10.1016/j.dsx.2018.11.054)

[12] A. Singh, R. Kukreti, L. Saso, S. Kukreti, Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes, Molecules, 27(3), 950(2022), DOI(https://doi.org/10.3390/molecules27030950)

[13] OO. Oguntibeju, Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links, International journal of physiology, pathophysiology and pharmacology, 11(3), 45(2019)

[14] S. Venugopa, Intertwined role of reactive oxygen, nitrogen and carbon in diabetic state, MOJ Cell Sci Rep., 2, 1-5(2015)

[15] H. Cheng, R. Harris, Renal endothelial dysfunction in diabetic nephropathy, Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders), 14(1), 22-33(2014)

[16] F. Hu, T. Zhang, Study on risk factors of diabetic nephropathy in obese patients with type 2 diabetes mellitus, International journal of general medicine, 351-360(2020), DOI(https://doi.org/10.2147/IJGM.S255858)

[17] Association AD. 6. Glycemic targets: standards of medical care in diabetes—2021. Diabetes Care, 2021, 44(Supplement_1), S73-S84.

[18] A. Cerise, JM. Chen, JA. Powelson, AJ. Lutz, JA. Fridell, Pancreas transplantation would be easy if the recipients were not diabetic: A practical guide to post‐operative management of diabetic complications in pancreas transplant recipients, Clinical Transplantation, 35(5), e14270(2021), DOI(https://doi.org/10.1111/ctr.14270)

[19] D. Care, Care in Diabetesd2018. Diabetes Care, 41(1), S137-S43(2018), DOI(https://doi.org/10.2337/dc18-S002)

[20] M. Sagoo, L. Gnudi, Diabetic nephropathy: an overview, Diabetic Nephropathy, (2020), DOI(https://doi.org/10.1007/978-1-4939-9841-8_1)

[21] JS. Bhatti, A. Sehrawat, J. Mishra, IS. Sidhu, U. Navik, N. Khullar, Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives, Free Radical Biology and Medicine, 184, 114-134(2022), DOI(https://doi.org/10.1016/j.freeradbiomed.2022.03.019)

[22] L. Rochette, M. Zeller, Y. Cottin, C. Vergely, Diabetes, oxidative stress and therapeutic strategies, Biochimica et Biophysica Acta (BBA)-General Subjects, 1840(9), 2709-2729(2014), DOI(https://doi.org/10.1016/j.bbagen.2014.05.017)

[23] NA. Meguid, AA. Dardir, ER. Abdel-Raouf, A. Hashish, Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation, Biological trace element research, 143, 58-65(2011), DOI(https://doi.org/10.1007/s12011-010-8840-9)

[24] J. K. Strecker, J. Minnerup, B. Gess, EB. Ringelstein, W. R. Schäbitz, M. Schilling, Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice, PloS one, 6(10), e25863(2011), DOI(https://doi.org/10.1371/journal.pone.0025863)

[25] N. Qamar, P. John, A. Bhatti, Emerging role of selenium in treatment of rheumatoid arthritis: An insight on its antioxidant properties, Journal of Trace Elements in Medicine and Biology, 66, 126737(2021), DOI(https://doi.org/10.1016/j.jtemb.2021.126737)

[26] H. Steinbrenner, LH. Duntas, MP. Rayman, The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities, Redox Biology, 50, 102236(2022), DOI(https://doi.org/10.1016/j.redox.2022.102236)

[27] M. Pauk, V. Kufner, V. Rumenovic, I. Dumic‑Cule, V. Farkas, M. Milosevic, Iron overload in aging Bmp6‑/‑mice induces exocrine pancreatic injury and fibrosis due to acinar cell loss, International Journal of Molecular Medicine, 47(4), 1-8(2021), DOI(https://doi.org/10.3892/ijmm.2021.4893)

[28] S. Chirumbolo, AP. Rossi, V. Rizzatti, E. Zoico, G. Franceschetti, D. Girelli, Iron primes 3T3-L1 adipocytes to a TLR4-mediated inflammatory response, Nutrition, 31(10), 1266-1274(2015), DOI(https://doi.org/10.1016/j.nut.2015.04.007)

[29] M. Andrews, M. Arredondo, Hepatic and adipocyte cells respond differentially to iron overload, hypoxic and inflammatory challenge, Biometals, 25, 749-759(2012), DOI(https://doi.org/10.1007/s10534-012-9543-9)

[30] D. Banerjee, G. Kaur, B. Chatterjee, H. Joshi, S. Ramniwas, HS.Tuli, Effectiveness of novel iron regulators in the treatment of diabetic nephropathy, (2023), DOI(10.15584/ejcem.2023.3.28)

[31] T. Ganz, Systemic iron homeostasis, Physiological reviews, 93(4), 1721-1741(2013), DOI(https://doi.org/10.1152/physrev.00008.2013)

Downloads

Published

2025-04-01

Issue

Vol. 3 No. 2 (2025)

Section

Articles

License

Copyright (c) 2025 CC BY 4.0

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

M. Al-Nadawi, H., & Al-Dulaimy, W. Y. M. (2025). Relationship of Serum Iron and Lipemic Levels with Inflammatory Biomarkers and Oxidative Stress in Diabetic Nephropathy. ., 3(2), 315-330. https://doi.org/10.24237/ASJ.03.02.862B